Extenta Jan 2023 Flashcards

1
Q

Dysbiosis and Diversity are two terms that are often used when discussing the microbiota.
Explain the terms in detail and describe the importance of them in human health.

A

Dysbiosis is an imbalance in the microbiome

Diversity is a measure of how many different species of bacteria are present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

The bacterial taxonomy uses hierarchical levels for classification. Choose three species (of
relevance within the topics intestinal microbiota and probiotics) belonging to different classes
and name them for all levels accordingly (from phyla to species), in the correct order and
starting with the highest level. Also use upper- or lower-case letters and italics in the correct
context.

A

Firmicutes
Bacilli
Lactobacillales
/Lactobacillacea
/Lactobacillus
/L. acidophilus

Proteobacteria
Gammaproteobacteria
Enterobacteriales
/Enterobacteriacea
/Eschericia
/E. coli

Actinobacteria
Actinobacteriia
Bifidobacterilales
/Bifidobacteriacea
/Bifidobacterium
/B. bifidum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

You are going to design a clinical trial to prove that probiotics can prevent diseases. Choose
one disease or syndrome that have been discussed during the course or is mentioned in the
compendium Probiotics (Molin G., 2022).
a) Describe the study design you have chosen and suggest suitable endpoints for the trial.
Motivate your answer.
b) Suggest one suitable probiotic species for the trial and explain how it can prevent the disease
that you have chosen.
c) Describe in detail the method you would have chosen for analysing the presence of the
probiotic species in the gastrointestinal tract.
d) Describe whether there is a risk of side effects from the probiotics you have chosen for the
individuals you want to give it to, as a preventive measure to reduce the risk of disease
development.

A

IBD would be an interesting disease from a probiotics viewpoint.
a) Randomised controlled trial. Two groups. One receives probiotics and the other a placebo. Endpoints for the trial would be a change in pain level/discomfort/bowel movement/flatulence
b) Lactobacillus plantarum 299V
c) Sanger sequencing using specific primers
d) There shouldn’t really be any risks, only that the first few days may feel a little different

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which are the typical dominating Gram-negative, and Gram-positive phyla that can be found
frequently in the intestinal tract of healthy human individuals? Name two Gram-negative and
one Gram-positive phyla.

A

Bacteroidetes (gram negative)
Proteobacteria (gram negative)
Firmicutes (gram positive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

All Gram-negative bacteria have pro-inflammatory compounds associated to the cell wall,
what is it called?

A

LPS lipopolysaccharides contain lipid A which is an endotoxin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe shortly (processes and involved cells and organs) how an inflammatory process can
be initiated in the small intestine by the microbiota.

A

Peyer’s patches present in the small intestine and contain specialised epithelial cells called M cells that sample the intestine for antigens. Dendritic cells are also present in the peyers patches and can also sample. These antigens are presented to T cells. Turn T cells into regulatory T cells. M cells can transport antigens via transcytosis. Dendritic cells can stick their dendrites through epithelial cells to sample.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Long-term inflammation is a risk factor for several diseases, name three diseases.

A

Inflammatory bowel’s disease. Autoimmune diseases. Metabolic diseases such as type 2 diabetes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T/F: Cytokines are always pro-inflammatory mediators.

A

False. Can also be anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T/F: All strains from the same species will act the same way

A

False
Example
HEAL9 and 299V have different properties

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T/F: Effects of probiotic treatments are dose-specific.

A

Need to be an adequate dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

T/F: Next generation sequencing is only detecting live cells.

A

False, it is about genetic material

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

T/F: Translocation is the passage of viable cells through the intestinal wall.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T/F: The genus Enterococcus but not Bifidobacterium are sometimes wrongly regarded as
LAB.

A

Enterococcus is a LAB but not bifidobacterium. So must be false.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

T/F: Staphylococcus belongs to the phylum Firmicutes

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T/F: Through phenotypic classification organisms are grouped together based on similar
observable characteristics.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T/F: Fermented plant-based products contain in general 10^5−7 lactic acid bacteria/ml or g

A

True

17
Q

T/F: Lactobacillus plantarum is now named Lactiplantibacillus plantarum.

A

True

18
Q

T/F: QPS in QPS list stands for Qualified Probiotic Species

A

No Qualitied Presumption of Safety

19
Q

T/F: The 18S rRNA gene is used for identification of bacterial strains.

A

False, 16S for bacteria, 18S for yeast

20
Q

T/F: Today there is non approved health claim on probiotic by EFSA.

A

No health claim specific to probiotics has been authorised in the EU

21
Q

In principle, what is the difference between bacterial identification and bacterial
classification?

A

You classify based on the different characteristics you can identify.

22
Q

Explain why the 16S rRNA gene is used for identification of bacteria?

A

Because it has both conserved and hypervariable regions

23
Q

Describe one traditional lactic acid fermented food based on plant-material (name of product,
production process, microorganisms involved, and estimated bacterial concentration in the
final product)

A

Kimchi
Sauerkraut
Lactic acid bacteria
Estimated bacterial conc is between 10^5-7 for fermented foods.

24
Q

Describe the concept transient microbiota (or variable microbiome) and reflect upon the
possibilities for the microorganisms in the fermented food mentioned in 7a, to affect the
composition of the gut microbiota after consumption.

A

The transient microbiome is passing through and not part of the core commensals but will still have an effect. Particularly if the probiotics is consumed regularly. While it may not colonise the gut it still has the potential to affect the composition of the microbiome.

25
Q

Describe in detail three different ways in which the microbiota can benefit healthy
individuals.

A

It helps to outcompete pathogens, synthesise essential vitamins and break down food that humans can’t such as dietary fibers, regulating the metabolism of host, help to balance the immune response, neurotransmitter production

26
Q

Mention four of the major factors influencing our gut microbiota composition?

A

Diet
Antibiotics use
Genetics
Lifestyle and environment

27
Q

Mention eight properties of an ideal probiotic.

A

The most important properties of strains to even be considered for probiotic use include: resistance to gastric acidity, bile acid resistance, adherence to mucus and/or human epithelial cells and cell lines, antimicrobial activity against potentially pathogenic bacteria or fungi, ability to reduce pathogen adhesion to surfaces, bile salt hydrolase activity, enhancing viability of probiotics.

28
Q

What is Next Generation Probiotics?

A

Notably, “traditional probiotic strains” were isolated from gut and traditional fermented foods. By contrast, NGPs have been recently isolated using new tools allowing isolation, identification, and modification of commensal bacterial species.

29
Q

Describe possible risks associated with the use of next gen probiotics.

A
30
Q

Describe schematically the different steps in Next Generation Sequencing using Illumina
MiSeq

A
31
Q

What can this method NGS preferably determine

A

Microbiome composition in the gut, sequences large data sets so makes sense to use it to “map out” all bacteria present

32
Q

Formulate a question within the topic of probiotics that seems relevant to you (naturally you
are not allowed to use or refer to any of the above questions), and then answer your own
question. The answer must be 500 words ± 10 %. The relevance of the question and the
quality of the answer will be evaluated and given a maximum of 10 points.

A
33
Q

Difference between identify and classify

A

Identification involves describing something in enough detail so that it could be recognised in a given context. Classifying is an investigative approach that involves sorting objects or events into groups or categories.

34
Q

Which bacteria dominates in sauerkraut?

A

L. plantarum

35
Q

Which bacteria dominates in kefir?

A

L. kefir

36
Q
A